David T Weaver Selected Research

PND 1186

1/2020	Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia.
8/2017	Inhibition of FAK kinase activity preferentially targets cancer stem cells.
1/2017	The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
1/2016	Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
5/2014	Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David T Weaver Research Topics

Disease

14	Neoplasms (Cancer) 01/2020 - 12/2010
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2017
3	Disease Progression 01/2020 - 01/2019
3	Breast Neoplasms (Breast Cancer) 08/2017 - 01/2011
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 10/2019
2	Malignant Mesothelioma 01/2019 - 05/2014
2	Triple Negative Breast Neoplasms 08/2017 - 12/2010
2	Adenocarcinoma 01/2017 - 01/2016
2	Squamous Cell Carcinoma of Head and Neck 01/2014 - 08/2011
2	Hemorrhage 10/2005 - 02/2005
1	Fatigue 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Leukemia 01/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2019
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2019
1	Mesothelioma 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 12/2018
1	Cough 12/2018
1	Fever (Fevers) 12/2018
1	Nausea 12/2018
1	Neutropenia 12/2018
1	Anemia 12/2018
1	Diarrhea 12/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 05/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2014
1	Pathologic Complete Response 05/2012
1	Esophageal Neoplasms (Esophageal Cancer) 05/2012
1	Thrombosis (Thrombus) 02/2005
1	Genomic Instability 01/2004
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2002

Drug/Important Bio-Agent (IBA)

7	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020 - 05/2014
6	Biomarkers (Surrogate Marker)IBA 01/2014 - 12/2010
5	PND 1186IBA 01/2020 - 05/2014
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2010
3	duvelisibIBA 01/2020 - 12/2018
3	defactinibIBA 01/2020 - 08/2017
3	PlatinumIBA 01/2019 - 08/2011
3	Phosphotransferases (Kinase)IBA 08/2017 - 12/2002
3	Formaldehyde (Formol)FDA Link 09/2012 - 01/2011
2	ofatumumab FDA Link 01/2020 - 12/2018
2	Neurofibromin 2 (Merlin)IBA 01/2019 - 05/2014
2	Aldehyde DehydrogenaseIBA 01/2019 - 05/2014
2	CateninsIBA 01/2019 - 07/2018
2	ParaffinIBA 09/2012 - 05/2012
2	DNA (Deoxyribonucleic Acid)IBA 08/2011 - 01/2004
1	venetoclaxIBA 01/2020
1	BilirubinIBA 01/2020
1	Rituximab (Mabthera)FDA Link 10/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2018
1	Deubiquitinating EnzymesIBA 07/2018
1	130-nm albumin-bound paclitaxelIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Gemcitabine FDA Link 01/2017
1	Collagen Type I (Type I Collagen)IBA 01/2017
1	P-2 (P 2)IBA 01/2017
1	VS-5584IBA 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	AsbestosIBA 05/2014
1	MAP-kinase-activated kinase 2IBA 01/2014
1	P 11 (P-11)IBA 09/2012
1	A-Form DNA (A-DNA)IBA 09/2012
1	AnthracyclinesIBA 09/2012
1	Keratins (Keratin)IBA 09/2012
1	Methotrexate (Mexate)FDA LinkGeneric 09/2012
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	Estrogen ReceptorsIBA 12/2010
1	AntibodiesIBA 12/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2010
1	Warfarin (Coumadin)FDA LinkGeneric 02/2005
1	CoagulantsIBA 02/2005
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2005

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 10/2019 - 08/2011
7	Therapeutics 10/2019 - 02/2005
1	Radioimmunotherapy 10/2019
1	Adjuvant Chemotherapy 01/2019
1	Oral Administration 08/2017
1	Immunotherapy 01/2016
1	Induction Chemotherapy 01/2014
1	Chemoradiotherapy 01/2014
1	Palliative Care (Palliative Therapy) 09/2012
1	Neoadjuvant Therapy 05/2012
1	Radiotherapy 08/2011